Maryland
Maryland Trend Analysis Report 2025
Maryland continues to be a leading hub for life sciences innovation, supported nearly 1,900 life sciences businesses and a strong research infrastructure, including the National Institutes of Health (NIH) and various federal laboratories. The 2024 analysis of Maryland’s life sciences sector highlights ongoing growth, particularly in biotechnology, digital health, and medical technology. While the state […]
23 Apr 2025
Read moreMaryland Life Science Trend Analysis 2024
Venture financing for Maryland’s life sciences industry in 2023 shows signs of recovery following the significant downturn in 2022, with the total value of private equity financing reaching USD 805m (up from USD 639m in 2022). For the biotech industry, the value of venture financing deals remained stable (USD 453m in 2022 vs. USD 451m […]
21 Mar 2024
Read moreMaryland Life Science Trend Analysis 2023
Maryland’s life science private equity investment landscape in 2022 shifted back to levels seen prior to the exceptional growth experienced in 2021. The total value of life science venture financing in Maryland dropped from USD 1.2 billion in 2021 to half that amount in 2022, with USD 558 million invested. Looking at the top venture […]
28 Jun 2023
Read moreMaryland Life Science Trend Analysis 2022
The life science industry in Maryland shows an upward trend in 2021, with an increase of 41% in private equity investment value of life science companies compared to the previous year. While there were 11 private equity rounds of biotech companies with a total investment of USD 302 million in 2020, the number of rounds […]
01 Jul 2022
Read more